Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan M Robbins

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Chest|February 4, 2009
Association of the metabolic syndrome with pulmonary venous hypertensionIvan M Robbins, John H Newman, Roger F Johnson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 12, 2015
Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" respondersStephen J Halliday, Anna R Hemnes, Ivan M Robbins, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 8, 2011
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extensionRaymond L Benza, Werner Seeger, Vallerie V McLaughlin, et al.
JACC. Heart Failure|September 10, 2013
Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertensionEvan L Brittain, Meredith E Pugh, Lisa A Wheeler, et al.
Circulation. Heart Failure|December 4, 2013
High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertensionIvan M Robbins, Anna R Hemnes, Meredith E Pugh, et al.
Circulation|July 27, 2014
ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive diseaseChristopher Lathen, Yu Zhang, Jennifer Chow, et al.
Journal of the American College of Cardiology|May 1, 2010
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trialVallerie V McLaughlin, Raymond L Benza, Lewis J Rubin, et al.
Pulmonary Circulation|March 13, 2014
Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular functionEvan L Brittain, Meredith E Pugh, Lisa A Wheeler, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 19, 2005
Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertensionJoy D Cogan, Cindy L Vnencak-Jones, John A Phillips, et al.
Journal of the American Heart Association|September 3, 2019
Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid ChallengeVineet Agrawal, Michele D'Alto, Robert Naeije, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Chest|February 4, 2009
Association of the metabolic syndrome with pulmonary venous hypertensionIvan M Robbins, John H Newman, Roger F Johnson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 12, 2015
Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" respondersStephen J Halliday, Anna R Hemnes, Ivan M Robbins, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 8, 2011
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extensionRaymond L Benza, Werner Seeger, Vallerie V McLaughlin, et al.
JACC. Heart Failure|September 10, 2013
Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertensionEvan L Brittain, Meredith E Pugh, Lisa A Wheeler, et al.
Circulation. Heart Failure|December 4, 2013
High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertensionIvan M Robbins, Anna R Hemnes, Meredith E Pugh, et al.
Circulation|July 27, 2014
ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive diseaseChristopher Lathen, Yu Zhang, Jennifer Chow, et al.
Journal of the American College of Cardiology|May 1, 2010
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trialVallerie V McLaughlin, Raymond L Benza, Lewis J Rubin, et al.
Pulmonary Circulation|March 13, 2014
Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular functionEvan L Brittain, Meredith E Pugh, Lisa A Wheeler, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 19, 2005
Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertensionJoy D Cogan, Cindy L Vnencak-Jones, John A Phillips, et al.
Journal of the American Heart Association|September 3, 2019
Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid ChallengeVineet Agrawal, Michele D'Alto, Robert Naeije, et al.
Pageof 8